James Walsh

Reporter | Medical Technology
Phone: 612-673-7428
James Walsh covers medical technology companies such as Medtronic and St. Jude and innovations.

Recent content from James Walsh

Obituary: Marvin Borman spent decades helping community

A community-centered and civic-minded organization seeking a spirted, committed, roll-up-your sleeves guy could not have chosen a better volunteer and advocate than Marvin Borman, friends and family say.

Updated: September 19, 2012, - 08:59 PM

Medtronic seeks drug company partner

It hopes to team up to develop a way to deliver Alzheimer's drugs directly into the brain.

Updated: September 17, 2012, - 11:14 PM

IT, health care come together

Preventice is out front in a coming health care trend harnessing mobile technology to better monitor vital signs.

Updated: September 15, 2012, - 09:18 PM

FDA OKs remote heart monitor

Developed with Mayo Clinic, BodyGuardian System allows doctors to track patients' heart rhythms from their offices.

Updated: September 10, 2012, - 09:21 PM

Mercy Hospital among first to try new heart scanner

The St. Jude system combines blood flow measurements with infrared scanning to find and remove blockages.

Updated: September 06, 2012, - 08:57 PM

St. Jude lays off 300, reorganizes

Analysts saw a connection to what St. Jude will have to pay in a new medical device tax. Officials said the goals are broader.

Updated: August 30, 2012, - 09:04 PM

Study backs St. Jude technology

Heart patients whose stents were placed with the help of PressureWire technology were far less likely to be rehospitalized.

Updated: August 28, 2012, - 08:37 PM

Medtronic therapy holds promise for some heart patients

A study presented in Munich shows the therapy, cardiac resynchronization, can reduce the size of enlarged hearts.

Updated: August 27, 2012, - 06:41 PM

CEO: Medtronic's focus paying off

The company must move beyond making devices, Omar Ishrak said, to providing technology and services across health care.

Updated: August 23, 2012, - 09:08 PM

Loosening a logjam on med-tech approvals

A meeting of U.S. senators, industry leaders and the head of the FDA revealed optimism, but also continuing concerns.

Updated: August 22, 2012, - 10:05 PM

Result Per Page

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters
Search by category

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT